Indian stocks: Visit www.stage2stocks.com →

The Cooper Companies, Inc.

Stage 4 · Declining · week 6

As of Oct 22, 2026, Cooper Companies is in Stage 4, the downtrend phase, now in week 6 (since Sep 16, 2026). It closed at $61.65, 26.9% below its 52-week high and below its 200-day average, which is falling.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. More about the company

$61.65
+4.54% today
$11.7B · Large cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is COO early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 33w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 4w → S3 3w → S4 10w → S1 7w → S2 13w → S3 13w → S4 5w → S1 1w → S2 11w → S3 7w → S4 33w → S1 1w → S4 10w → S1 4w → S2 12w → S3 6w → S4 11w → S1 9w → S4 5w current
Total tracked: 165 weeks across 19 stage runs.

COO among Medical Instruments & Supplies31st of 51 by relative strength

All 51 →
Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#StockStageRS1M
1PLSEStage 2 · wk 3498+1.3%
2PDEXStage 2 · wk 3697−13.3%
3HBIOStage 2 · wk 1195+3.6%
4ATRCStage 2 · wk 1089−1.1%
5WSTStage 2 · wk 2482+4.8%
6BDXStage 2 · wk 1181+9.8%
7ICUIStage 3 · wk 181+3.1%
8OSURStage 3 · wk 875−4.8%
…31COOStage 4 · wk 641+10.0%
vs 52W High
-26.9%
$53.27 lo$84.32 hi
26.9% below 52W high, ongoing decline
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 6
1w13w26w
Week 6, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-11.4%
200 DMA: $69.58 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.95x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↗ ⇈
Short-term trend rising gently, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+10.0%
3M
-12.3%
6M
-5.1%
YTD
-24.0%
1Y
-17.8%
Scan Membership
Breakout Watch
Latest: 2024-09-11
7 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 6 · Vol 0.95x
2026-10-21S4
Wk 6 · Vol 0.39x
2026-10-20S4
Wk 5 · Vol 0.55x
2026-10-19S4
Wk 5 · Vol 0.73x
2026-10-16S4
Wk 5 · Vol 1.03x
2026-10-15S4
Wk 5 · Vol 0.80x
2026-10-14S4
Wk 5 · Vol 0.95x
2026-10-13S4
Wk 4 · Vol 0.73x
2026-10-12S4
Wk 4 · Vol 0.95x
2026-10-09S4
Wk 4 · Vol 0.90x
2026-10-08S4
Wk 4 · Vol 1.69x
2026-10-07S4
Wk 4 · Vol 1.34x
Moving averages & range
50 DMA
$62.23
200 DMA
$69.58
52W High
$84.32
52W Low
$53.27
5D Low
$57.94
Resistance levels (recent highs)
20d High
$61.65
60d High
$76.82
120d High
$76.82
250d High
$84.32
Next resistance
+24.6%
to 60d High
P/E (TTM)
21.2
Forward 13.1
Earnings Growth (YoY)
+357.1%
Revenue +0.6%
ROE
+6.8%
Profit margin +13.5%
Dividend Yield
0.00%
P/B 1.4

Cooper Companies: quick answers

What stage is Cooper Companies in?

As of Oct 22, 2026, Cooper Companies (COO) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 16, 2026 and is in week 6. What the four stages mean

Is Cooper Companies in an uptrend?

No. Cooper Companies is in a Stage 4 downtrend. It trades 11.4% below its 200-day average, which is falling.

How far is Cooper Companies from its 52-week high?

Cooper Companies closed at $61.65 on Oct 22, 2026, 26.9% below its 52-week high of $84.32. Its 52-week low is $53.27.

How has Cooper Companies performed over the past year?

As of Oct 22, 2026, Cooper Companies is down 17.8% over the past year and down 24.0% so far in 2026.

Which sector and industry is Cooper Companies in?

Cooper Companies is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.